BioNTech SE 22UA-DE:XETRA

*Data is delayed | EUR
Last | 5:35 PM CEST
240.00quote price arrow down-3.10 (-1.28%)
Volume
91,564
52 week range
65.50 - 395.00
Loading...
  • Open243.90
  • Day High247.50
  • Day Low238.10
  • Prev Close243.10
  • 52 Week High395.00
  • 52 Week High Date08/10/21
  • 52 Week Low65.50
  • 52 Week Low Date12/29/20

Key Stats

  • Market Cap67,224.97M
  • Shares Out241.52M
  • 10 Day Average Volume160,487.36
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change228.86

KEY STATS

  • Open243.90
  • Day High247.50
  • Day Low238.10
  • Prev Close243.10
  • 52 Week High395.00
  • 52 Week High Date08/10/21
  • 52 Week Low65.50
  • 52 Week Low Date12/29/20
  • Market Cap67,224.97M
  • Shares Out241.52M
  • 10 Day Average Volume160,487.36
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change228.86

RATIOS/PROFITABILITY

  • EPS (TTM)16.35
  • P/E (TTM)14.68
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO17:4117:41
How Tiny BioNTech Emerged As A Powerhouse In The Covid Vaccine Race

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany